|
1
|
Zhao B, Han H, Chen J, Zhang Z, Li S, Fang
F, Zheng Q, Ma Y, Zhang J, Wu N and Yang Y: MicroRNA let-7c
inhibits migration and invasion of human non-small cell lung cancer
by targeting ITGB3 and MAP4K3. Cancer Lett. 342:43–51. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gao L, Qiu H, Liu J, Ma Y, Feng J, Qian L,
Zhang J, Liu Y and Bian T: KLF15 promotes the proliferation and
metastasis of lung adenocarcinoma cells and has potential as a
cancer prognostic marker. Oncotarget. 8:109952–109961. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Waqar SN, Samson PP, Robinson CG, Bradley
J, Devarakonda S, Du L, Govindan R, Gao F, Puri V and Morgensztern
D: Non-small-cell lung cancer with brain metastasis at
presentation. Clin Lung Cancer. 19:e373–e379. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nguyen DX, Chiang AC, Zhang XH, Kim JY,
Kris MG, Ladanyi M, Gerald WL and Massagué J: WNT/TCF signaling
through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.
Cell. 138:51–62. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jin L, Chun J, Pan C, Kumar A, Zhang G, Ha
Y, Li D, Alesi GN, Kang Y, Zhou L, et al: The PLAG1-GDH1 axis
promotes anoikis resistance and tumor metastasis through
CamKK2-AMPK signaling in LKB1-deficient lung cancer. Mol Cell.
69:87–99 e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji H, Ramsey MR, Hayes DN, Fan C, McNamara
K, Kozlowski P, Torrice C, Wu MC, Shimamura T, Perera SA, et al:
LKB1 modulates lung cancer differentiation and metastasis. Nature.
448:807–810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rosales KR, Reid MA, Yang Y, Tran TQ, Wang
WI, Lowman X, Pan M and Kong M: TIPRL inhibits protein phosphatase
4 activity and promotes H2AX phosphorylation in the DNA damage
response. PLoS One. 10:e01459382015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakashima A, Tanimura-Ito K, Oshiro N,
Eguchi S, Miyamoto T, Momonami A, Kamada S, Yonezawa K and Kikkawa
U: A positive role of mammalian Tip41-like protein, TIPRL, in the
amino-acid dependent mTORC1-signaling pathway through interaction
with PP2A. FEBS Lett. 587:2924–2929. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chatzimichail E, Matthaios D, Bouros D,
Karakitsos P, Romanidis K, Kakolyris S, Papashinopoulos G and Rigas
A: γ-H2AX: A novel prognostic marker in a prognosis prediction
model of patients with early operable non-small cell lung cancer.
Int J Genomics. 2014:1602362014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matthaios D, Hountis P, Karakitsos P,
Bouros D and Kakolyris S: H2AX a promising biomarker for lung
cancer: A review. Cancer Invest. 31:582–599. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roy D, Sin SH, Lucas A, Venkataramanan R,
Wang L, Eason A, Chavakula V, Hilton IB, Tamburro KM, Damania B and
Dittmer DP: mTOR inhibitors block Kaposi sarcoma growth by
inhibiting essential autocrine growth factors and tumor
angiogenesis. Cancer Res. 73:2235–2246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou H and Huang S: Role of mTOR signaling
in tumor cell motility, invasion and metastasis. Curr Protein Pept
Sci. 12:30–42. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Paquette M, El-Houjeiri L and Pause A:
mTOR pathways in cancer and autophagy. Cancers (Basel). 10(pii):
E182018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang L, Graham PH, Ni J, Hao J, Bucci J,
Cozzi PJ and Li Y: Targeting PI3K/Akt/mTOR signaling pathway in the
treatment of prostate cancer radioresistance. Crit Rev Oncol
Hematol. 96:507–517. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian L, Zhao Z, Xie L and Zhu J:
MiR-361-5p suppresses chemoresistance of gastric cancer cells by
targeting FOXM1 via the PI3K/Akt/mTOR pathway. Oncotarget.
9:4886–4896. 2017.PubMed/NCBI
|
|
16
|
Yoon JY, Lee JJ, Gu S, Jung ME, Cho HS,
Lim JH, Jun SY, Ahn JH, Min JS, Choi MH, et al: Novel
indazole-based small compounds enhance TRAIL-induced apoptosis by
inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.
Oncotarget. 8:112610–112622. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui F, Hu J, Ning S, Tan J and Tang H:
Overexpression of MCM10 promotes cell proliferation and predicts
poor prognosis in prostate cancer. Prostate. 78:1299–1310. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kroiss A, Vincent S, Decaussin-Petrucci M,
Meugnier E, Viallet J, Ruffion A, Chalmel F, Samarut J and Allioli
N: Androgen-regulated microRNA-135a decreases prostate cancer cell
migration and invasion through downregulating ROCK1 and ROCK2.
Oncogene. 34:2846–2855. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park JY and Juhnn YS: cAMP signaling
increases histone deacetylase 8 expression via the Epac2-Rap1A-Akt
pathway in H1299 lung cancer cells. Exp Mol Med. 49:e2972017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song IS, Jun SY, Na HJ, Kim HT, Jung SY,
Ha GH, Park YH, Long LZ, Yu DY, Kim JM, et al: Inhibition of
MKK7-JNK by the TOR signaling pathway regulator-like protein
contributes to resistance of HCC cells to TRAIL-induced apoptosis.
Gastroenterology. 143:1341–1351. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kundu ST, Grzeskowiak CL, Fradette JJ,
Gibson LA, Rodriguez LB, Creighton CJ, Scott KL and Gibbons DL:
TMEM106B drives lung cancer metastasis by inducing TFEB-dependent
lysosome synthesis and secretion of cathepsins. Nat Commun.
9:27312018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grzeskowiak CL, Kundu ST, Mo X, Ivanov AA,
Zagorodna O, Lu H, Chapple RH, Tsang YH, Moreno D, Mosqueda M, et
al: In vivo screening identifies GATAD2B as a metastasis driver in
KRAS-driven lung cancer. Nat Commun. 9:27322018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brody H: Lung cancer. Nature. 513:S12014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takeyama Y, Sato M, Horio M, Hase T,
Yoshida K, Yokoyama T, Nakashima H, Hashimoto N, Sekido Y, Gazdar
AF, et al: Knockdown of ZEB1, a master epithelial-to-mesenchymal
transition (EMT) gene, suppresses anchorage-independent cell growth
of lung cancer cells. Cancer Lett. 296:216–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han J, Wang F, Lan Y, Wang J, Nie C, Liang
Y, Song R, Zheng T, Pan S, Pei T, et al: KIFC1 regulated by
miR-532-3p promotes epithelial-to-mesenchymal transition and
metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
Oncogene. 38:406–420. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang X, Peng Y, Jiang X, Lu X, Duan W,
Zhang S, Dai N, Shan J, Feng Y, Li X, et al: The regulatory role of
APE1 in epithelial-to-mesenchymal transition and in determining
EGFR-TKI responsiveness in non-small-cell lung cancer. Cancer Med.
7:4406–4419. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei X, Li Q, Li Y, Duan W, Huang C, Zheng
X, Sun L, Luo J, Wang D, Zhang S, et al: Prediction of survival
prognosis of non-small cell lung cancer by APE1 through regulation
of Epithelial-Mesenchymal Transition. Oncotarget. 7:28523–28539.
2016.PubMed/NCBI
|
|
28
|
Zhang Y, Zhang X, Ye M, Jing P, Xiong J,
Han Z, Kong J, Li M, Lai X, Chang N, et al: FBW7 loss promotes
epithelial-to-mesenchymal transition in non-small cell lung cancer
through the stabilization of Snail protein. Cancer Lett. 419:75–83.
2018. View Article : Google Scholar : PubMed/NCBI
|
